SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.
Financial Results:
SMS Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹135.34 Crores up from ₹64.39 Crore year on year, a rise of 110.19%.
Total Expenses for Q1FY24 of ₹123.17 Crores up from ₹77.98 Crores year on year, a rise of 57.95%.
Consolidated Net Profit of ₹9.34 Crores from -₹12.77 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.10, from -₹1.51 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.